Faecal calprotectin in primary care: is its current use supported by the evidence?

被引：0
|
作者：
Perry, Robert W. [1 ,2 ,3 ,5 ]
Mummery, David [4 ]
Alexander, James L. [1 ,2 ,3 ]
Hicks, Lucy C. [1 ,2 ,3 ]
Williams, Horace R. T. [1 ,2 ,3 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Gastroenterol, London, England
[2] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Hepatol, London, England
[3] Imperial Coll London, Fac Med, Dept Metab Digest & Reprod, Div Digest Dis, London, England
[4] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England
[5] Imperial Coll Healthcare NHS Trust, St Marys Hosp, The Bays,South Wharf Rd, London W2 1NY, England
来源：
BRITISH JOURNAL OF GENERAL PRACTICE | 2024年 / 74卷 / 740期
关键词：
INFLAMMATORY-BOWEL-DISEASE; IBD;
D O I：
10.3399/bjgp24X736665
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：134 / 136
页数：3
相关论文
共 50 条
  • [31] Faecal calprotectin testing in patients presenting with lower gastrointestinal symptoms; a retrospective primary care study in the United Kingdom.
    Umar, N.
    Wambua, S.
    Adderley, N. J.
    Haroon, S.
    Trudgill, N.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I765 - I765
  • [32] THE USE OF FAECAL CALPROTECTIN AS A SCREENING TOOL FOR REFERRING PATIENTS WITH POSSIBLE IBD
    Fernandes, Darren
    Mathew, Aarati
    Elphick, David
    GUT, 2019, 68 : A235 - A236
  • [33] How to use faecal calprotectin in management of paediatric inflammatory bowel disease
    Saha, Amit
    Tighe, Mark P.
    Batra, Akshay
    ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION, 2016, 101 (03): : 124 - 128
  • [34] Faecal calprotectin remains high with the primary therapy nutritional in Crohn's disease
    Navas, V
    Blasco, J.
    Sierra, C.
    Barco, A.
    Vicioso, I
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 44 : 257 - 257
  • [35] Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study
    Hogberg, Cecilia
    Karling, Pontus
    Rutegard, Jorgen
    Lilja, Mikael
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (01) : 69 - 75
  • [36] Faecal Calprotectin as an evidence-based medicine biomarker of inflammatory bowel disease
    Caro Miro, M. A.
    Gomez Vera, S.
    Herranz Arriero, L.
    Morales Lomas, J. J.
    CLINICA CHIMICA ACTA, 2019, 493 : S509 - S509
  • [37] Evaluation of the clinical and cost-effectiveness of the York Faecal Calprotectin Care Pathway
    Turvill, James
    Turnock, Daniel
    Holmes, Hayden
    Jones, Alison
    Mclaughlan, Eleanor
    Hilton, Victoria
    Marriott, Stacey
    FRONTLINE GASTROENTEROLOGY, 2018, 9 (04) : 285 - 294
  • [38] The use of faecal calprotectin testing to inform management of patients with inflammatory bowel disease
    Loebenstein, Moshe
    Shrestha, Atul
    Xia, Bowen
    Sun, Georgia
    Moore, Gregory
    Boyapati, Ray
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 258 - 259
  • [39] FROM DIARRHOEA TO DIAGNOSIS: AN ANALYSIS OF FAECAL CALPROTECTIN USE IN AN IBD REFERRAL PATHWAY
    Faulkes, Rosemary
    Magrabi, Malik
    Townson, Gilian
    Rees, Megan
    Watkins, Thomas
    Richmond, Katherine
    GUT, 2018, 67 : A76 - A76
  • [40] Effect of faecal calprotectin testing on referrals for children with chronic gastrointestinal symptoms in primary care: study protocol for a cluster randomised controlled trial
    Ansems, Sophie
    Berger, Marjolein
    van Rheenen, Patrick
    Vermeulen, Karin
    Beugel, Gina
    Couwenberg, Maria
    Holtman, Gea
    BMJ OPEN, 2021, 11 (07):
12345